Trials / Completed
CompletedNCT07131839
Central Sensitization Presence on the Results of Shoulder Adhesive Capsulitis
Effects of Central Sensitization Presence on the Results of Shoulder Adhesive Capsulitis Treatment With Physical Therapy Agents and Exercise
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Ankara City Hospital Bilkent · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Patients with adhesive capulitis longlasting more than 3 months were participated in the study. they were divided into two groups whether they have central sensitizaiton or not. Conventional physical therapy responses were measured and compared between two groups.
Detailed description
Adhesive capsulitis is a well known musculoskeletal syndrome that effects daily living activities and patiemts suffer from chronic shoulder pain. Central sensitization has been defined in patients with chronic pain due to amplified neuronal connections and signals in the central nervous system. Previously, it was shown that refractory long lasting musculoskeletal disorders may show challenging treatment process and decreased outcome due to central sensitization. However to the best of our knowledge there was not any study that evaluates the treatment response of presence of central sensitization in adhesive capsulitis patients. Total of 32 adhesive capsulitis patients were particapted in the study. Sixteen patients with adhesive capsulitis with (Group 1) and without central sensitization (Group 2) were received conventional physical therapy and exercise. Treatment response were evaluated with Visual Analog Scale (VAS), Shoulder pain and disability index (SPADI) Tampa Kinesiophobia Scale (TKS) and Pain Catastrophizing Scale (PCS). Additionally shoulder range of motion was measured at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2).
Conditions
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2025-08-20
- Last updated
- 2025-08-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07131839. Inclusion in this directory is not an endorsement.